Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 4

Sponsor Class

OTHER 4OTHER_GOV 2INDUSTRY 2

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Gynecologic 4Breast 3Tumor-Agnostic 2Thoracic 2Genitourinary 2Sarcoma 1NET 1Head & Neck 1Gastrointestinal 1Endocrine 1

Conditions

Ovarian Neoplasms 3Uterine Neoplasms 1Kenny-Caffey syndrome, Type 1 1Endometrial Neoplasms 1

Interventions

Paclitaxel 268Carboplatin 264Cisplatin 194Bevacizumab 135pembrolizumab 99Surveys and Questionnaires 84Radiotherapy 77Cyclophosphamide 75olaparib 67Blood Specimen Collection 65Drug Therapy 62Hyperthermic Intraperitoneal Chemotherapy 60Gemcitabine 60niraparib 56Topotecan 56Brachytherapy 54liposomal doxorubicin 52Taxes 47Docetaxel 46Magnetic Resonance Spectroscopy 43Letrozole 36Cytoreduction Surgical Procedures 36Filgrastim 33Biopsy 33Surgical Procedures, Operative 32durvalumab 31Specimen Handling 31Doxorubicin 31Nivolumab 30Albumin-Bound Paclitaxel 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Poly(ADP-ribose) Polymerase Inhibitors × Gynecologic × Clear all
NCT04724031 2023-03-14

Real World Data Analysis of PARP Inhibitors Use in Patients With Ovarian Cancer

Hellenic Cooperative Oncology Group

Unknown
150 enrolled
Gynecologic

Ovarian Neoplasms

NCT05044091 2021-09-14

HOPEI

Jiangsu Cancer Institute & Hospital

Unknown
100 enrolled
Gynecologic

Kenny-Caffey syndrome, Type 1, Ovarian Neoplasms

NCT03951415 2021-04-01

DOMEC

Leiden University Medical Center

Phase 2 Unknown
55 enrolled
Gynecologic

Uterine Neoplasms, Endometrial Neoplasms

NCT04582552 2021-01-20

ROMP

Jiangsu Cancer Institute & Hospital

Unknown
60 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡